About Quine Biologics
Quine Biologics is a Technology company based in New York (United States) founded in 2023 by Brett Spurrier. It develops custom AI-designed antibodies for researchers and clinicians in biotechnology. It operates on a B2B model. Quine Biologics offers products and services including AI-Designed Antibodies and SE3 De-noising Diffusion. Its focus areas include Healthcare, Biotechnology, Antibody Design and AI-Assisted. Its legal entity is Quine Biologics, Inc. Its competitors include GenScript, Epitomics and Vector Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
Quine Biologics uses AI and deep learning technologies to create bespoke antibodies for protein targets, enabling rapid design in hours rather than months. The company focuses on therapeutic-grade solutions for healthcare and biotechnology, serving researchers and clinicians globally. Based in New York, USA, it emphasizes efficiency, cost reduction, and high-quality standards in immunotherapies and personalized medicine.
- Headquarters New York, United States
- Founders Brett Spurrier
- SectorsTechnology
- Email••••••••
- Website quinebiologics.com
- Legal Name Quine Biologics, Inc
Products & Services of Quine Biologics
Quine Biologics offers a comprehensive portfolio of products and services, including AI-Designed Antibodies and SE3 De-noising Diffusion.
Custom AI tools for rapid antibody candidate design and development.
Platform for building antibody CDRs directly into protein epitopes efficiently.
People of Quine Biologics
1 people are tracked at Quine Biologics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Brett Spurrier | Founder | Leadership |
Complete people profiles for Quine Biologics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Quine Biologics
Quine Biologics has 3 listed competitors in our database, 2 of them funded. They include GenScript, Epitomics and Vector Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | Monoclonal antibody technology and products are developed by Epitomics. | ||
| vectorlabs.com | 1976 | Burlingame, United States | Labeling and detection reagents immunohistochemistry studies and other life science research applications |
Detailed competitors of Quine Biologics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Quine Biologics
Complete news archive for Quine Biologics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quine Biologics
Quine Biologics was founded in 2023.
Quine Biologics is headquartered in New York, United States. It is registered at New York, New York, United States.
Quine Biologics uses AI and deep learning technologies to create bespoke antibodies for protein targets, enabling rapid design in hours rather than months. The company focuses on therapeutic-grade solutions for healthcare and biotechnology, serving researchers and clinicians globally. Based in New York, USA, it emphasizes efficiency, cost reduction, and high-quality standards in immunotherapies and personalized medicine.
Quine Biologics's top competitors include GenScript, Epitomics and Vector Laboratories.
Quine Biologics offers AI-Designed Antibodies and SE3 De-noising Diffusion.
Quine Biologics operates through Quine Biologics, Inc.